- US Youth Tobacco Use Declines, but Flavored Products Remain Popular
- Mazdutide and Orforglipron—New Evidence in Obesity and Diabetes
- GLP-1 Drugs Associated With Smell and Taste Disruptions
- Smallpox—Old and New
- Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
- Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes Research Summary
- A Push to Expand Testosterone Therapy Access
- Decision-Support Tool for Antidepressant Treatment of Patients With Major Depressive Disorder
- Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes
- Patient Information: Peripheral Neuropathy
- Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity Research Summary
- Learning to Listen
- Alzheimer Disease Biomarkers and Assisted Dying
- Decision-Support Tool for Antidepressant Treatment of Patients With Major Depressive Disorder—Reply
- Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain Research Summary
